In patients with T2DM, vitamin C supplementation has been shown to reduce plasma levels of malondialdehyde (MDA), improve endothelial-dependent vasodilation, and decrease markers of systemic inflammation, such as C-reactive protein (CRP) and interleukin-6 (IL-6) [58]. This evidence concerns the gene CRP and type 2 diabetes mellitus.